ARCH Venture Partners wraps up 12th fund at nearly $3bn
ARCH Venture Fund XII will back early-stage biotech companies.
ARCH Venture Fund XII will back early-stage biotech companies.
Copyright PEI Media
Not for publication, email or dissemination
